Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.04 EUR | -0.97% | -4.10% | -19.76% |
06-14 | Restrictions on glyphosate remain in place | DP |
06-13 | Archer-Daniels-Midland, Bayer to Expand Regenerative Agriculture Program to Eastern Europe | MT |
Chart calendar Bayer AG
Upcoming events on Bayer AG
Past events on Bayer AG
2024-05-18 12:30 | American College of Obstetricians and Gynecologists Clinical & Scientific Meeting - E-Poster #IP05-C |
2024-05-18 12:30 | American College of Obstetricians and Gynecologists Clinical & Scientific Meeting - E-Poster #IP05-D |
2024-05-18 10:00 | American College of Obstetricians and Gynecologists Clinical & Scientific Meeting - JoAnn V. Pinkert |
2024-05-17 20:15 | American College of Obstetricians and Gynecologists Clinical & Scientific Meeting - James A |
2024-05-17 13:30 | American College of Obstetricians and Gynecologists Clinical & Scientific Meeting - E-Poster #IP01-A |
2024-05-17 13:30 | American College of Obstetricians and Gynecologists Clinical & Scientific Meeting - E-Poster #IP01-B |
2024-05-14 08:00 | Q1 2024 Earnings Call |
2024-05-14 01:30 | Q1 2024 Earnings Release |
2024-04-28 | Détachement de for final dividend |
2024-04-26 04:00 | Annual General Meeting |
2024-03-05 08:00 | Capital Markets Day - Q4 2023 Earnings |
2024-03-05 03:30 | Q4 2023 Earnings Call |
2024-03-05 01:30 | Q4 2023 Earnings Release |
2024-01-15 02:00 | UniCredit Kepler Cheuvreux German Corporate Conference |
2024-01-09 14:15 | JPMorgan Healthcare Conference |
2023-11-21 08:00 | OCEANIC-AF Phase III Trial Update Call |
2023-11-08 08:00 | Q3 2023 Earnings Call |
2023-11-08 01:30 | Q3 2023 Earnings Release |
2023-10-19 | European Society for Medical Oncology Congress |
2023-09-26 | Citi European Healthcare Bus Tour |
Past dividends on Bayer AG
2024-04-28 | Annual 0.11 EUR |
2023-05-01 | Annual 2.4 EUR |
2022-05-01 | Annual 2 EUR |
2021-04-27 | Annual 2 EUR |
2020-04-28 | Annual 2.8 EUR |
2019-04-28 | Annual 2.8 EUR |
2018-05-27 | Annual 2.8 EUR |
2017-04-30 | Annual 2.7 EUR |
2016-05-01 | Annual 2.5 EUR |
2015-05-27 | 2.25 EUR |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 43 545 43 968 -0.96% | 41 400 41 796 -0.95% | 44 081 43 294 1.82% | 50 739 50 664 0.15% | 47 637 47 587 0.1% | 47 092 |
EBITDA Million EUR | Released Forecast Spread | 11 503 11 611 -0.93% | 11 461 11 726 -2.26% | 11 179 11 149 0.27% | 13 513 13 377 1.02% | 10 632 11 031 -3.62% | 10 286 |
EBIT Million EUR | Released Forecast Spread | 7 007 7 922 -11.55% | 7 095 7 073 0.31% | 7 295 7 420 -1.68% | 9 257 8 940 3.55% | 7 589 7 381 2.82% | 6 656 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 2 880 3 826 -24.73% | -17 250 -18 018 4.26% | 2 046 1 237 65.4% | 4 670 5 985 -21.97% | -1 621 -1 358 -19.36% | 3 786 |
Net income Million EUR | Released Forecast Spread | 4 091 3 123 30.99% | -10 495 -12 097 13.24% | 1 000 671 49.02% | 4 150 4 435 -6.43% | -2 941 -1 998 -47.23% | 2 334 |
EPS EUR | Released Forecast Spread | 4,17 2,95 41.34% | -10,7 -13,3 19.9% | 1,02 0,64 59.65% | 4,22 4,48 -5.85% | -2,99 -3,02 0.95% | 2,28 |
Announcement Date | 27/02/20 | 25/02/21 | 01/03/22 | 28/02/23 | 05/03/24 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2020 S2 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 22 899 23 681 -3.3% | 18 501 18 540 -0.21% | 14 639 13 729 6.63% | 12 819 12 281 4.38% | 11 281 10 946 3.06% | 12 000 12 078 -0.65% | 14 389 14 585 -1.34% | 11 044 11 847 -6.78% | 10 342 10 448 -1.01% | 11 862 11 731 1.12% | 13 765 14 086 -2.28% | 11 052 | 24 831 | 10 376 | 11 963 | 22 454 |
EBITDA Million EUR | Released Forecast Spread | 7 274 17 926 -59.42% | 5 251 4 692 11.92% | 3 349 3 188 5.05% | 2 451 2 388 2.63% | 2 462 2 574 -4.34% | 4 471 4 650 -3.85% | 2 527 2 694 -6.19% | 1 685 1 801 -6.46% | 3 023 2 276 32.83% | 4 412 4 242 4% | 2 341 | 6 738 | 1 623 | 2 315 | 3 941 | |
EBIT Million EUR | Released Forecast Spread | 4 172 3 625 15.08% | 2 280 2 200 3.62% | 1 352 1 329 1.75% | 1 453 1 792 -18.92% | 3 404 3 210 6.03% | 1 534 1 312 16.9% | 709 958 -26.01% | 1 942 1 849 5.02% | 3 299 2 733 20.7% | 1 269 | 789 | 1 280 | ||||
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 3 722 2 955 25.98% | -523 1 556 -133.61% | 601 941 -36.13% | 870 1 808 -51.87% | 2 606 2 569 1.46% | -1 574 234 -772.65% | -4 297 680 -731.91% | 1 644 673 144.28% | ||||||||
Net income Million EUR | Released Forecast Spread | 3 291 2 314 42.23% | -298 1 293 -123.05% | 546 570 -4.19% | 611 853 -28.39% | 2 178 1 872 16.34% | -1 887 | -4 569 393 -1262.9% | 1 337 584 128.86% | 2 000 1 438 39.12% | 84,5 | -306 | -201 | ||||
EPS EUR | Released Forecast Spread | 3,35 2,36 42.14% | -0,30 1,31 -122.87% | 0,56 0,60 -6.62% | 0,62 0,97 -36.28% | 2,22 1,90 16.6% | -1,92 | -4,66 0,41 -1226.26% | 1,36 0,59 128.58% | 2,04 1,46 39.37% | 0,09 | -0,31 | -0,21 | ||||
Announcement Date | 04/08/20 | 25/02/21 | 10/05/22 | 04/08/22 | 08/11/22 | 28/02/23 | 11/05/23 | 08/08/23 | 08/11/23 | 05/03/24 | 13/05/24 | - | - | - | - | - |
Past sector events for Bayer AG
2024-06-13 17:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
2024-05-30 08:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 | FDC LIMITED: Q4 2024 Earnings Release |
2024-05-29 05:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:44 | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BAYN Stock
- BAYN Stock
- Calendar Bayer AG